We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
4-(Tert-butyl)-2,6-bis(1-phenylethyl)phenol induces pro-apoptotic activity.
- Authors
Jun Ho Kim; Yunmi Lee; Mi-Yeon Kim; Jae Youl Cho
- Abstract
Previously, we found that KTH-13 isolated from the butanol fraction of Cordyceps bassiana (Cb-BF) displayed anti-cancer activity. To improve its antiproliferative activity and production yield, we employed a total synthetic approach and derivatized KTH-13 to obtain chemical analogs. In this study, one KTH-13 derivative, 4-(tert-butyl)-2,6-bis(1-phenylethyl)phenol (KTH-13-t-Bu), was selected to test its anti-cancer activity. KTH-13-t-Bu diminished the proliferation of C6 glioma, MDA-MB-231, LoVo, and HCT-15 cells. KTH-13-t-Bu induced morphological changes in C6 glioma cells in a dose-dependent manner. KTH-13-t-Bu also increased the level of early apoptotic cells stained with annexin V-FITC. Furthermore, KTH- 13-t-Bu increased the levels of cleaved caspase-3 and -9. In contrast, KTH-13-t-Bu upregulated the levels of pro- and cleaved forms of caspase-3, -8, and -9 and Bcl- 2. Phospho-STAT3, phospho-Src, and phospho-AKT levels were also diminished by KTH13-t-Bu treatment. Therefore, these results strongly suggest that KTH-13-t-Bu can be considered a novel anti-cancer drug displaying pro-apoptotic activity.
- Subjects
ANTINEOPLASTIC agents; APOPTOTIC bodies; APOPTOTIC protease-activating factor 1; CORDYCEPS; CHEMICAL derivatives
- Publication
Korean Journal of Physiology & Pharmacology, 2016, Vol 20, Issue 3, p2583
- ISSN
1226-4512
- Publication type
Article
- DOI
10.4196/kjpp.2016.20.3.253